Molecular effects of proinsulin C-peptide (Q34756498)

4 August 2017

1 reference

title

Molecular effects of proinsulin C-peptide (English)

1 reference

4 August 2017

Alexander Chibalin

5

0 references

John Wahren

6

object named as

John Wahren

1 reference

4 August 2017

1

Jan Johansson

1 reference

4 August 2017

Karin Ekberg

2

1 reference

4 August 2017

Jawed Shafqat

3

1 reference

4 August 2017

Mikael Henriksson

4

1 reference

4 August 2017

Hans Jörnvall

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Biochemical and Biophysical Research Communications

4 August 2017

1 reference

4 August 2017

295

1 reference

4 August 2017

5

1 reference

4 August 2017

1035-1040

1 reference

Proinsulin: recent observations and controversies

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Proinsulin and C-peptide: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Proinsulin C-peptide--biological activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Effects of C-peptide on renal function at the early stage of experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Effects of C-peptide on glomerular and renal size and renal function in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Unordered structured of proinsulin C-peptide in aqueous solution and in the presence of lipid vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

High affinity binding sites for proinsulin in human IM-9 lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

High affinity binding sites for proinsulin on human umbilical vein endothelial cells (HUVEC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Specific binding of proinsulin C-peptide to human cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide binding to human cell membranes: importance of Glu27.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Molecular basis for the insulinomimetic effects of C-peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Activation of orphan receptors by the hormone relaxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Endocrinology. This hormone has been relaxin' too long!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

C-peptide improves autonomic nerve function in IDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900721-0

10.1016/S0006-291X(02)00721-0

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference